NISA INVESTMENT ADVISORS, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,936
-78.2%
1,964
-66.3%
0.00%
Q2 2023$41,085
+171087.5%
5,836
+50.8%
0.00%
Q1 2023$24
+100.0%
3,871
+106.3%
0.00%
Q4 2022$12
-100.0%
1,876
-70.9%
0.00%
-100.0%
Q3 2022$60,000
-17.8%
6,438
-2.7%
0.00%0.0%
Q2 2022$73,000
+942.9%
6,614
+1459.9%
0.00%
Q1 2022$7,0000.0%4240.0%0.00%
Q4 2021$7,000
-65.0%
424
-48.3%
0.00%
Q3 2021$20,000
-88.0%
820
-87.1%
0.00%
-100.0%
Q2 2021$166,000
-17.8%
6,3690.0%0.00%0.0%
Q1 2021$202,000
-31.8%
6,3690.0%0.00%
-50.0%
Q4 2020$296,000
+55.0%
6,369
+10.0%
0.00%0.0%
Q3 2020$191,000
+11.7%
5,791
-7.3%
0.00%0.0%
Q2 2020$171,000
+557.7%
6,245
+625.3%
0.00%
Q1 2020$26,000
+36.8%
861
+22.8%
0.00%
Q4 2019$19,000
+46.2%
7010.0%0.00%
Q3 2019$13,000
-43.5%
701
-26.2%
0.00%
Q2 2019$23,000
+155.6%
9500.0%0.00%
Q1 2019$9,000
-18.2%
950
-20.8%
0.00%
Q4 2018$11,000
+83.3%
1,200
+135.3%
0.00%
Q3 2018$6,000
-33.3%
510
-27.1%
0.00%
Q2 2018$9,000
-25.0%
7000.0%0.00%
Q1 2018$12,0007000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Perceptive Advisors 12,201,261$203,150,0004.07%
Paradigm Biocapital Advisors LP 907,428$15,109,0004.00%
Avoro Capital Advisors LLC 9,125,000$151,931,0002.77%
Logos Global Management LP 1,000,000$16,650,0002.16%
Avidity Partners Management LP 6,043,219$100,620,0002.10%
Orbimed Advisors 6,633,006$110,440,0001.79%
Parametrica Management Ltd 134,679$2,240,0001.66%
Boxer Capital, LLC 1,935,133$32,220,0001.66%
Fairmount Funds Management LLC 389,588$6,487,0001.53%
Long Focus Capital Management, LLC 705,000$11,738,0001.51%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders